Home > products > custom-nanocomposites
> fluorescent-labeled-nanocomposites
> dops-dopc-chol-dope-n-dbco-20-49-30-1-molar-ratio-based-fluoroliposome-dir-dbco
DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiR-DBCO
DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiR-DBCO
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-Mcs-231 | 1EA | inquiry | ||
|
Product description
DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiR-DBCO can encapsulate therapeutic agents, allowing for targeted and controlled drug delivery in oncology or other therapeutic applications.The far-red fluorescence from DiR allows for non-invasive imaging of liposomes in vivo, useful for tracking distribution and pharmacokinetics.The DBCO moiety allows for the attachment of different biomolecules, creating a versatile platform for developing probes for diagnostics or therapeutic applications.
Appearance | Freeze-dried powder |
---|---|
DOPS:DOPC:Chol:DOPE-N-DBCO | 20:49:30:1molar ratio |
DiR-Excitation/Emission | 750/780nm |
Liposome Size | 100 nm |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 3 weeks |
Stability | 1 year |
Document
Related Product